Laryngeal Plasmacytosis Responsive to Inhaled Budesonide

alexandrossfakianakis shared this article with you from Inoreader Laryngeal Plasmacytosis Responsive to Inhaled Budesonide via The Laryngoscope Laryngeal mucous membrane plasmacytosis is rare and treatment options are limited. We present the case of a patient demonstrating remarkable improvement with the use of nebulized corticosteroid therapy. Mucous membrane plasmacytosis (MMP) is rare condition characterized by diffuse plasma cell infiltration of upper aero-digestive tract mucosa. It results in epithelial hyperplasia that has a classic papillary appearance. We describe a case of MMP primarily affect laryngeal and oropharyngeal mucosa resulting in progressive airway obstruction. We highlight airway management and histopathology. The patient had near complete clinical response with inhaled budesonide, which has not yet been described as a treatment option in the literature. Laryngoscope, 2022 View on Web

Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.